Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent Clp protease proteolytic subunit (ClpP) is a highly conserved serine protease found in bacteria and the mitochondria of eukaryotic cells. It forms a cylindrical tetradecameric (14-mer) complex that degrades misfolded or damaged proteins, collaborating with AAA+ ATPase chaperones (e.g., ClpX, ClpA, ClpC) that target and unfold substrates for translocation into ClpP’s proteolytic chamber. In bacteria, ClpP is essential for adaptation to stress, virulence, and cell survival, making it a promising antimicrobial drug target. In humans, mitochondrial ClpP helps maintain mitochondrial protein quality, with mutations linked to Perrault syndrome (characterized by hearing loss and ovarian abnormalities). Pharmacological modulation of ClpP (activation or inhibition) can result in bacterial death or impaired mitochondrial function, and several small-molecule modulators are under active study as antibacterials and anticancer agents. ClpP is a member of the S14 peptidase family, uses an internal serine-histidine-aspartate catalytic triad for peptide bond hydrolysis, and is assembled as a barrel with its active sites sequestered within the chamber. Its function and regulation are critical both for cellular adaptation and as an emerging therapeutic target in infection and potentially cancer.
ClpP activators (ADEPs, ONC201): cause uncontrolled proteolysis leading to cell death. ClpP inhibitors (β-lactones): block proteolytic activity, preventing protein turnover and bacterial adaptation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent Clp protease proteolytic subunit (ClpP).